Archive: European Medicines Agency

Showing 231 to 240 of 575 entries

	Title
2012-03-16	Press Release: European Medicines Agency confirms positive benefit-risk balance of Protelos/Osseor but recommends new contraindications and revised warnings Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/185175/2012 (16.3.12) Published: 16/03/2012 (Last update: 16/03/2012)
2012-03-05	Press Release: European Medicines Agency publishes updated set of mandatory Article 57(2) requirements for marketing authorisation holders Author (Corporate): European Medicines Agency Series Details: Press Release EMA/139333/2012 (5.3.12) Published: 05/03/2012 (Last update: 05/03/2012)
2012-03-01	European Medicines Agency publishes list of human medicines under evaluation Author (Corporate): European Medicines Agency Series Details: News 1.3.12 Published: 01/03/2012 (Last update: 01/03/2012)
2012-02-29	European Medicines Agency launches call for expression of interest from healthcare professional organisations Author (Corporate): European Medicines Agency Series Details: News 29.2.12 Published: 29/02/2012 (Last update: 29/02/2012)
2012-02-22	European Medicines Agency releases good pharmacovigilance practice modules for public consultation Author (Corporate): European Medicines Agency Series Details: News 22.2.12 Published: 22/02/2012 (Last update: 22/02/2012)
2012-02-17	Press Release: European Medicines Agency recommends new anti-malaria treatment for use outside the European Union Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/114875/2012 (17.2.12) Published: 17/02/2012 (Last update: 17/02/2012)
2012-02-17	Press Release: European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/123373/2012 (17.2.12) Published: 17/02/2012 (Last update: 17/02/2012)
2012-02-17	Press Release: European Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin’s B-cell lymphoma Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/121961/2012 (17.2.12) Published: 17/02/2012 (Last update: 17/02/2012)
2012-02-17	Press Release: European Medicines Agency to publish information on ongoing medicine evaluations Author (Corporate): European Medicines Agency Series Details: Press Release EMA/123332/2012 (17.2.12) Published: 17/02/2012 (Last update: 17/02/2012)
2012-02-17	Press Release: European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/112042/2012 (17.2.12) Published: 17/02/2012 (Last update: 17/02/2012)